药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Clotiazepam
Abituzumab
Estradiol valerate may increase the thrombogenic activities of Abituzumab.
Clotiazepam
Sifalimumab
Estradiol valerate may increase the thrombogenic activities of Sifalimumab.
Clotiazepam
Demcizumab
Estradiol valerate may increase the thrombogenic activities of Demcizumab.
Clotiazepam
Carlumab
Estradiol valerate may increase the thrombogenic activities of Carlumab.
Clotiazepam
Intetumumab
Estradiol valerate may increase the thrombogenic activities of Intetumumab.
Clotiazepam
Ibalizumab
Estradiol valerate may increase the thrombogenic activities of Ibalizumab.
Clotiazepam
Lumretuzumab
Estradiol valerate may increase the thrombogenic activities of Lumretuzumab.
Clotiazepam
Tovetumab
Estradiol valerate may increase the thrombogenic activities of Tovetumab.
Clotiazepam
Dacetuzumab
Estradiol valerate may increase the thrombogenic activities of Dacetuzumab.
Clotiazepam
Bimagrumab
Estradiol valerate may increase the thrombogenic activities of Bimagrumab.
Clotiazepam
Blosozumab
Estradiol valerate may increase the thrombogenic activities of Blosozumab.
Clotiazepam
Mavrilimumab
Estradiol valerate may increase the thrombogenic activities of Mavrilimumab.
Clotiazepam
Inebilizumab
Estradiol valerate may increase the thrombogenic activities of Inebilizumab.
Clotiazepam
Plozalizumab
Estradiol valerate may increase the thrombogenic activities of Plozalizumab.
Clotiazepam
Mogamulizumab
Estradiol valerate may increase the thrombogenic activities of Mogamulizumab.
Clotiazepam
Bococizumab
Estradiol valerate may increase the thrombogenic activities of Bococizumab.
Clotiazepam
Indusatumab vedotin
Estradiol valerate may increase the thrombogenic activities of Indusatumab vedotin.
Clotiazepam
Fresolimumab
Estradiol valerate may increase the thrombogenic activities of Fresolimumab.
Clotiazepam
Dusigitumab
Estradiol valerate may increase the thrombogenic activities of Dusigitumab.
Clotiazepam
Fezakinumab
Estradiol valerate may increase the thrombogenic activities of Fezakinumab.